OXAZEPAM MYLAN oxazepam 30mg tablet bottle

Land: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

oxazepam, Quantity: 30 mg

Fáanlegur frá:

Bafna Pharmaceuticals Pty Ltd

Lyfjaform:

Tablet, uncoated

Samsetning:

Excipient Ingredients: magnesium stearate; lactose monohydrate; quinoline yellow; maize starch; erythrosine

Stjórnsýsluleið:

Oral

Einingar í pakka:

25 tablets, 90 tablets, 50 tablets, 1000 tablets

Gerð lyfseðils:

(S4) Prescription Only Medicine

Ábendingar:

INDICATIONS AS AT 25 JANUARY 2005 : OXAZEPAM MYLAN is indicated for: Management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety associated with depression is also responsive to oxazepam therapy. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The physician should periodically reassess the usefulness of the drug for the individual patient. Alcoholics with acute tremulousness, confusional state or anxiety associated with alcohol withdrawal are responsive to therapy.

Vörulýsing:

Visual Identification: 8 mm pale orange flat bevelled edged tablet marked OM/30 on one side, G on reverse; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Leyfisstaða:

Registered

Leyfisdagur:

2021-10-11